Tirzepatide GLN19 (Q19) Deamidation Impurity Reference Standard Package Size:50mgDescription Tirzepatide GLN19 deamidation impurity is a high purity impurity reference standard used for impurity profiling, analytical method development, and quality control of Tirzepatide. Deamidation at glutamine residue 19 is a well characterized degradation pathway in peptide drug substances that can be monitored by HPLC and LC MS. This reference standard supports accurate detection and quantification of deamidated species, ensuring product
glutathione peroxidases are also involved in modulating these processes
Alternatively spliced transcript variants encoding different isoforms have been identified for this gene
Full name ATG4C rabbit monoclonal antibody Alternative names 50 μl/100 μl Reactivity rabbit monoclonal Applications WB
These two variants encode the same isoform
please wash with 5 mL of purified water per square centimeter
Color-Coded Sample Organization: Available in assorted colors to support visual sample classification and improve identification efficiency in research laboratories and biobanking workflows
Alternatively spliced transcript variants encoding either the same or different isoforms have been identified for this gene
Full name SNX3 rabbit polyclonal antibody Alternative names 50 μl/100 μl Reactivity rabbit polyclonal Applications WB
thus coupling pre- and post-mRNA splicing events
Immunohistochemical analysis of paraffin-embedded Human thyroid cancer tissue or AFP antigen-treated (Neutralization experiment) using P104481(AFP Antibody) at dilution 1/25
Rich Nutrient Composition — Formulated with high‑quality tryptone and yeast extract to supply essential peptides
Swissprot No P08253 Gene Accession NP_001121363 WB Predicted band size 74 kDa WB Positive control WB Recommended dilution 500-2000 IHC predicted cell location Predicted cell location: Cytoplasm IHC positive control Positive control: Human breast cancer IHC Recommed dilution Recommended dilution: 50-100 Storage
